APA (7th ed.) Citation

Buoninfante, O. A., Pilzecker, B., Aslam, M. A., Zavrakidis, I., van der Wiel, R., van de Ven, M., . . . Jacobs, H. (2018). Precision cancer therapy: Profiting from tumor specific defects in the DNA damage tolerance system. Oncotarget, 9(27), 18832. https://doi.org/10.18632/oncotarget.24777

Chicago Style (17th ed.) Citation

Buoninfante, Olimpia Alessandra, Bas Pilzecker, Muhammad Assad Aslam, Ioannis Zavrakidis, Rianne van der Wiel, Marieke van de Ven, Paul C M. van den Berk, and Heinz Jacobs. "Precision Cancer Therapy: Profiting from Tumor Specific Defects in the DNA Damage Tolerance System." Oncotarget 9, no. 27 (2018): 18832. https://doi.org/10.18632/oncotarget.24777.

MLA (9th ed.) Citation

Buoninfante, Olimpia Alessandra, et al. "Precision Cancer Therapy: Profiting from Tumor Specific Defects in the DNA Damage Tolerance System." Oncotarget, vol. 9, no. 27, 2018, p. 18832, https://doi.org/10.18632/oncotarget.24777.